Valuation (16%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 41,730.24 | -17.50 |
| PEG Ratio (TTM) | -305.92 | -5.53 |
| P/S Ratio (TTM) | N/A | 34.44 |
| P/B Ratio (TTM) | 1.65 | 5.76 |
| P/FCF Ratio (TTM) | -48.65 | -146.44 |
| Price to 5YR AVG Earnings Ratio | N/A | -34.29 |
| Price to 5YR AVG FCF Ratio | N/A | -1.09 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.00% | 287.39% |
| ROE (TTM) | 0.00% | -4,212.65% |
| Net Profit Margin (TTM) | N/A | -1,034.52% |
| ROIC 5YR AVG | N/A | -16.31% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -27.45% | -7,778.28% | N/A |
| Revenue | N/A | N/A | N/A |
| Net Income | -6.45% | -35,479.51% | N/A |
| Cash Flow | -15.78% | -27,038,907.65% | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.00 | 4.93 |
| Quick Ratio (TTM) | 0.00 | 4.91 |
| D/E Ratio (TTM) | 0.03 | 1.27 |
| Interest Coverage (TTM) | -0.84 | -11.12 |
| Piotroski F-Score | 3 | 3 |
| Altman Z-Score | 8.32 | 20.75 |
| LTL to 5YR AVG FCF | N/A | -0.53 |
| Shares Outstanding Growth 5YR AVG | N/A | 621.48% |